{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:12:36Z","timestamp":1786997556705,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.toxicon.2022.02.024","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T02:13:40Z","timestamp":1646273620000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Solving the microheterogeneity of Bothrops asper myotoxin-II by high-resolution mass spectrometry: Insights into C-terminal region variability in Lys49-phospholipase A2 homologs"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-6469","authenticated-orcid":false,"given":"Bruno","family":"Lomonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2022.02.024_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1258\/td.2009.090266","article-title":"Amputation and disability following snakebite in Nigeria","volume":"40","author":"Abubakar","year":"2010","journal-title":"Trop. Doct."},{"key":"10.1016\/j.toxicon.2022.02.024_bib2","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/pr800332p","article-title":"Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations","volume":"7","author":"Alape-Gir\u00f3n","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxicon.2022.02.024_bib64","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cimb44010004","article-title":"Lessons from a single amino acid substitution: anticancer and antibacterial properties of two phospholipase A2-derived peptides","volume":"44","author":"Almeida","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejmech.2018.02.055","article-title":"A novel synthetic peptide inspired on Lys49 phospholipase A2 from Crotalus oreganus abyssus snake venom active against multidrug-resistant clinical isolates","volume":"149","author":"Almeida","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.toxicon.2022.02.024_bib4","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1074\/jbc.M410588200","article-title":"A molecular mechanism for Lys49-phospholipase A2 activity based on ligand induced conformational change","volume":"280","author":"Ambrosio","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2022.02.024_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1107\/S0907444994011455","article-title":"Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom","volume":"51","author":"Arni","year":"1995","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.toxicon.2022.02.024_bib6","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1038\/s41598-017-15614-z","article-title":"PLA2-like proteins myotoxic mechanism: a dynamic model description","volume":"7","author":"Borges","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2022.02.024_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijbiomac.2021.09.083","article-title":"BthTX-II from Bothrops jararacussu venom has variants with different oligomeric assemblies: an example of snake venom phospholipases A2 versatility","volume":"191","author":"Borges","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac029","article-title":"Sequence slider: integration of structural and genetic data to characterize isoforms from natural sources","author":"Borges","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2022.02.024_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.toxicon.2019.07.004","article-title":"Isolation of two basic phospholipases A2 from Bothrops diporus snake venom: comparative characterization and synergism between Asp49 and Lys49 variants","volume":"168","author":"Bustillo","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1042\/BST20210288","article-title":"What's in a mass?","volume":"49","author":"Calvete","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.toxicon.2022.02.024_bib11","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/toxins5101780","article-title":"Molecular characterization of Lys49 and Asp49 phospholipases A2 from snake venom and their antiviral activities against Dengue virus","volume":"5","author":"Cecilio","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2022.02.024_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00239-002-2400-7","article-title":"Interisland evolution of Trimeresurus flavoviridis venom phospholipase A2 isozymes","volume":"56","author":"Chijiwa","year":"2003","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1042\/bj20020092","article-title":"Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2","volume":"366","author":"Chioato","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2022.02.024_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbamem.2007.01.023","article-title":"Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis","volume":"1768","author":"Chioato","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2022.02.024_bib15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00018-009-9053-2","article-title":"Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of receptors","volume":"66","author":"Cintra-Francischinelli","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2022.02.024_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.toxicon.2009.10.013","article-title":"The C-terminal region of a Lys49 myotoxin mediates Ca2+ influx in C2C12 myotubes","volume":"55","author":"Cintra-Francischinelli","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.toxicon.2022.02.024_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2174\/092986609788923392","article-title":"Calcium-independent membrane damage by venom phospholipases A2","volume":"16","author":"de Oliveira","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.toxicon.2022.02.024_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsb.2009.04.003","article-title":"Comparative structural studies on Lys49-phospholipases A2 from Bothrops genus reveal their myotoxic site","volume":"167","author":"dos Santos","year":"2009","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib20","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.bbapap.2014.09.015","article-title":"A structure-based proposal for a comprehensive myotoxic mechanism of phospholipase A2-like proteins from viperid snake venoms","volume":"1844","author":"Fernandes","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2022.02.024_bib21","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1111\/febs.12386","article-title":"Muscle phospholipid hydrolysis by Bothrops asper Asp49 and Lys49 phospholipase A2 myotoxins - distinct mechanisms of action","volume":"280","author":"Fern\u00e1ndez","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.toxicon.2022.02.024_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxicon.2022.02.024_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0003-9861(91)90307-5","article-title":"Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2","volume":"284","author":"Francis","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.toxicon.2022.02.024_bib24","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.3390\/molecules26164896","article-title":"Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors","volume":"26","author":"Freire","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.toxicon.2022.02.024_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biologicals.2009.01.010","article-title":"Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region","volume":"37","author":"Gebrim","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.toxicon.2022.02.024_bib26","doi-asserted-by":"crossref","first-page":"16252","DOI":"10.1038\/s41598-020-73134-9","article-title":"The allosteric activation mechanism of a phospholipase A2-like toxin from Bothrops jararacussu venom: a dynamic description","volume":"10","author":"Gomes","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2022.02.024_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijbiomac.2017.04.013","article-title":"BmajPLA2-II, a basic Lys49-phospholipase A2 homologue from Bothrops marajoensis snake venom with parasiticidal potential","volume":"102","author":"Grabner","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0892-0354(90)90001-9","article-title":"Muscle necrosis caused by snake venoms and toxins","volume":"3","author":"Harris","year":"1990","journal-title":"Electron. Microsc. Rev."},{"key":"10.1016\/j.toxicon.2022.02.024_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2010.04.001","article-title":"Unique structural characteristics and evolution of a cluster of venom phospholipase A2 isozyme genes of Protobothrops flavoviridis snake","volume":"461","author":"Ikeda","year":"2010","journal-title":"Gene"},{"key":"10.1016\/j.toxicon.2022.02.024_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.toxicon.2022.02.024_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0041-0101(93)90143-7","article-title":"Isolation of a myotoxin from the venom of Agkistrodon contortrix laticinctus (broad-banded copperhead) and pathogenesis of myonecrosis induced by it in mice","volume":"31","author":"Johnson","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-3011.1989.tb01575.x","article-title":"A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides","volume":"34","author":"Kini","year":"1989","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.toxicon.2022.02.024_bib33","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"Mega X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib34","first-page":"325","article-title":"Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper","volume":"102B","author":"Lomonte","year":"1992","journal-title":"Comp. Biochem. Physiol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0041-0101(89)90039-1","article-title":"A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)","volume":"27","author":"Lomonte","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib36","first-page":"647","article-title":"Phospholipases A2 from Viperidae snake venoms: how do they induce skeletal muscle damage?","volume":"58","author":"Lomonte","year":"2011","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.toxicon.2022.02.024_bib37","series-title":"Handbook of Venoms and Toxins of Reptiles","first-page":"389","article-title":"Snake venom phospholipase A2 toxins","author":"Lomonte","year":"2021"},{"key":"10.1016\/j.toxicon.2022.02.024_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.toxicon.2012.02.007","article-title":"Snake venom Lys49 myotoxins: from phospholipases A2 to non-enzymatic membrane disruptors","volume":"60","author":"Lomonte","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40409-017-0117-8","article-title":"Strategies in 'snake venomics' aiming at an integrative view of compositional, functional, and immunological characteristics of venoms","volume":"23","author":"Lomonte","year":"2017","journal-title":"JVATiTD"},{"key":"10.1016\/j.toxicon.2022.02.024_bib40","doi-asserted-by":"crossref","first-page":"29867","DOI":"10.1016\/S0021-9258(18)43961-0","article-title":"Neutralizing interaction between heparins and myotoxin II, a Lys-49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling","volume":"269","author":"Lomonte","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2022.02.024_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-0101(03)00149-1","article-title":"Comparative study of synthetic peptides corresponding to region 115-129 in Lys49 myotoxic phospholipases A2 from snake venoms","volume":"42","author":"Lomonte","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.toxicon.2003.11.008","article-title":"An overview of Lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action","volume":"42","author":"Lomonte","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib43","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1016\/S0021-9258(18)89822-2","article-title":"A new class of phospholipases A2 with lysine in place of aspartate 49","volume":"259","author":"Maraganore","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2022.02.024_bib44","first-page":"47","article-title":"Remote South American snakebite with extensive myonecrosis","volume":"1","author":"Means","year":"2017","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"10.1016\/j.toxicon.2022.02.024_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0163-7258(90)90081-C","article-title":"Myotoxic components of snake venoms: their biochemical and biological activities","volume":"48","author":"Mebs","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.toxicon.2022.02.024_bib46","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00018-008-8113-3","article-title":"Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action","volume":"65","author":"Montecucco","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2022.02.024_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109846","article-title":"Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo","volume":"9","author":"Mora-Obando","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2022.02.024_bib48","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jmb.2005.04.072","article-title":"Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin","volume":"350","author":"Murakami","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2022.02.024_bib49","first-page":"330","article-title":"Fungicidal activity of a phospholipase A2-derived synthetic peptide variant upon Candida albicans","volume":"20","author":"Murillo","year":"2007","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"10.1016\/j.toxicon.2022.02.024_bib50","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1073\/pnas.92.12.5605","article-title":"Accelerated evolution in the protein-coding regions is universal in crotalinae snake venom gland phospholipase A2 isozyme genes","volume":"92","author":"Nakashima","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxicon.2022.02.024_bib51","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0041-0101(01)00141-6","article-title":"Identification of the myotoxic site of the Lys49 phospholipase A2 from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities","volume":"39","author":"N\u00fa\u00f1ez","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.toxicon.2003.11.003","article-title":"Molecular evolution of myotoxic phospholipases A2 from snake venom","volume":"42","author":"Ohno","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib53","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1432-1327.1998.2530452.x","article-title":"Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region","volume":"253","author":"P\u00e1ramo","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2022.02.024_bib54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins13040290","article-title":"Short linear motifs characterizing snake venom and mammalian phospholipases A2","volume":"13","author":"Peggion","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2022.02.024_bib55","doi-asserted-by":"crossref","first-page":"11627","DOI":"10.1016\/S0021-9258(17)39077-4","article-title":"A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom","volume":"260","author":"Renetseder","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2022.02.024_bib56","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1021\/bi00164a018","article-title":"Calcium ion independent membrane leakage induced by phospholipase-like myotoxins","volume":"31","author":"Rufini","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2022.02.024_bib57","doi-asserted-by":"crossref","first-page":"10317","DOI":"10.1038\/s41598-018-28584-7","article-title":"Structural and functional characterization of suramin-bound MjTX-I from Bothrops moojeni suggests a particular myotoxic mechanism","volume":"8","author":"Salvador","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2022.02.024_bib58","doi-asserted-by":"crossref","first-page":"129913","DOI":"10.1016\/j.bbagen.2021.129913","article-title":"The synthetic varespladib molecule is a multi-functional inhibitor for PLA2 and PLA2-like ophidic toxins","volume":"1865","author":"Salvador","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2022.02.024_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxicon.2021.03.015","article-title":"Understanding the mechanism of action of peptide (p-BthTX-I)2 derived from C-terminal region of phospholipase A2 (PLA2)-like bothropstoxin-I on Gram-positive and Gram-negative bacteria","volume":"196","author":"Santos-Filho","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0041-0101(97)00133-5","article-title":"A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity","volume":"36","author":"Soares","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2022.02.024_bib61","doi-asserted-by":"crossref","first-page":"787368","DOI":"10.3389\/fmolb.2021.787368","article-title":"Molecular architecture of the antiophidic protein DM64 and its binding specificity to myotoxin II from Bothrops asper venom","volume":"8","author":"Soares","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.toxicon.2022.02.024_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj3620089","article-title":"Active site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis","volume":"362","author":"Ward","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2022.02.024_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(09)61754-2","article-title":"Snakebite","volume":"375","author":"Warrell","year":"2010","journal-title":"Lancet"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010122000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010122000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:21:58Z","timestamp":1758576118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010122000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":64,"alternative-id":["S0041010122000654"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2022.02.024","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solving the microheterogeneity of Bothrops asper myotoxin-II by high-resolution mass spectrometry: Insights into C-terminal region variability in Lys49-phospholipase A2 homologs","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2022.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}